- Home
- NUKK vs ICU Comparison
NUKK vs ICU Comparison
Compare NUKK & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUKK
- ICU
- Stock Information
- Founded
- NUKK 2013
- ICU 2018
- Country
- NUKK United States
- ICU United States
- Employees
- NUKK N/A
- ICU N/A
- Industry
- NUKK Blank Checks
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- NUKK Finance
- ICU Health Care
- Exchange
- NUKK Nasdaq
- ICU Nasdaq
- Market Cap
- NUKK 25.4M
- ICU 25.6M
- IPO Year
- NUKK N/A
- ICU N/A
- Fundamental
- Price
- NUKK $5.33
- ICU $0.86
- Analyst Decision
- NUKK
- ICU
- Analyst Count
- NUKK 0
- ICU 0
- Target Price
- NUKK N/A
- ICU N/A
- AVG Volume (30 Days)
- NUKK 11.5M
- ICU 1.1M
- Earning Date
- NUKK 11-14-2025
- ICU 11-12-2025
- Dividend Yield
- NUKK N/A
- ICU N/A
- EPS Growth
- NUKK N/A
- ICU N/A
- EPS
- NUKK N/A
- ICU N/A
- Revenue
- NUKK N/A
- ICU $766,000.00
- Revenue This Year
- NUKK N/A
- ICU $894.81
- Revenue Next Year
- NUKK N/A
- ICU $71.78
- P/E Ratio
- NUKK N/A
- ICU N/A
- Revenue Growth
- NUKK N/A
- ICU N/A
- 52 Week Low
- NUKK $1.30
- ICU $0.31
- 52 Week High
- NUKK $78.32
- ICU $5.22
- Technical
- Relative Strength Index (RSI)
- NUKK 52.17
- ICU 53.00
- Support Level
- NUKK $4.25
- ICU $0.82
- Resistance Level
- NUKK $6.66
- ICU $0.91
- Average True Range (ATR)
- NUKK 0.79
- ICU 0.07
- MACD
- NUKK 0.23
- ICU -0.00
- Stochastic Oscillator
- NUKK 47.31
- ICU 48.31
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.